EQ — Equillium Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of cel… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$2.32
Market Cap$130M
Float31.5M
Shares Outstanding63.2M
P/E (Forward)1.53
Price/Sales (TTM)20.22
vs. Analyst Target+174.8% to analyst PT
Revenue (TTM)$4.4M
Dividend RateNone
Analyst Target Price$6.38 (2 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$29.8M -$45,000 -$29.5M
2021 N/A -$39.0M -$72,000 -$37.7M
2022 $15.8M -$62.4M $15.8M -$61.3M
2023 $36.1M -$13.3M $36.1M -$12.1M
2024 $41.1M -$8.1M $41.1M -$7.6M
2025 $130,000 -$22.4M -$116,000 -$23.5M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$5.7M
Sep 2025 N/A -$4.2M
Dec 2025 N/A -$3.8M
Mar 2026 N/A -$5.3M

Ownership & Float

Insider Ownership16.4%
Institutional Ownership64.2%
Short Float8.9%
% of All Funds Holding0.56%
Number of Funds Holding46

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$2.08Near-term / short-term trend
Weekly40-Week SMA$1.61Medium-term trend
Weekly80-Week SMA$1.12Cyclical trend (business cycle)
Weekly200-Week SMA$1.15Secular trend (multi-year)
Monthly10-Month SMA$1.66Near-term monthly trend
Monthly20-Month SMA$1.11Medium-term monthly trend
Monthly40-Month SMA$1.05Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$0.40 support 8.14x 8 months ago

Historical Earnings Reactions (31 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.09% 0.00% 41.94% 6.74% -9.65%
1 Day 1.66% 0.33% 51.61% 44.83% -16.33%
1 Week 2.31% -0.14% 45.16% 66.07% -23.75%
2 Weeks 3.41% 0.53% 50.00% 114.29% -33.33%
1 Month 2.32% -6.97% 36.67% 241.07% -60.56%

Next earnings: August 1, 2026 (65 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.5%75.0%8
Feb32.1%62.5%8
Mar-15.4%37.5%8
Apr-11.8%37.5%8
May3.9%71.4%7
Jun-15.2%14.3%7
Jul32.7%57.1%7
Aug55.7%71.4%7
Sep-8.6%14.3%7
Oct-6.9%28.6%7
Nov-9.1%25.0%8
Dec-1.4%50.0%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 1.74% 40.9% 359
Tuesday -0.28% 40.6% 394
Wednesday -0.01% 42.5% 391
Thursday 0.44% 45.7% 383
Friday 0.35% 46.6% 384

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 64.2%

Insider Transactions — Smart Summary

Total insider ownership: 16.4%

Founder-led management: Bruce D. Steel (Chief Executive Officer & Director), Stephen Connelly (Chief Scientific Officer & President)

12-Month Insider Activity Summary

Total Filings8
Net Value-$957,008.141
Net Shares Change-79,193
% of Float-0.3%
C-Suite Filings8
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Zedelmayer Christine Sr. Vice President and COO -$948,580.571 7 N/A
Tom Penny Principal Accounting Officer -$8,427.57 1 N/A

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-10 Zedelmayer Christine Sr. Vice President and COO -$242,834.615 Transaction at $1.39, now +66.6%
2025-12-15 Zedelmayer Christine Sr. Vice President and COO -$47,486.32 Transaction at $1.33, now +74.4%
2025-11-25 Zedelmayer Christine Sr. Vice President and COO -$7,696.339 Transaction at $0.95, now +144.1%
2026-03-16 Zedelmayer Christine Sr. Vice President and COO -$206,371.174 Transaction at $1.64, now +41.2%
2026-03-10 Zedelmayer Christine Sr. Vice President and COO -$186,346.061 Transaction at $1.26, now +83.6%
2026-02-23 Zedelmayer Christine Sr. Vice President and COO -$186,346.061 Transaction at $1.26, now +83.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Equillium Inc (EQ) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for EQ on Trend Edge →